Document is current
Any future updates will be listed below
-
Authors
Furukawa, Toshi A. https://orcid.org/0000-0003-2159-3776
Iwata, Susumu
Horikoshi, Masaru
Sakata, Masatsugu
Toyomoto, Rie
Luo, Yan
Tajika, Aran
Kudo, Noriko
Aramaki, Eiji
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP22de0107005)
Japan Society for the Promotion of Science (21K03049)
Japan Society for the Promotion of Science (23K02915)
Japan Society for the Promotion of Science (23K02935)
- License Information
-
More Information
Article History
Accepted: 30 June 2023
First Online: 7 July 2023
Declarations
:
: TAF reports personal fees from Boehringer-Ingelheim, DT Axis, Kyoto University Original, Shionogi and SONY, and a grant from Shionogi, outside the submitted work; In addition, TAF has patents 2020-548587 and 2022-082495 pending, and intellectual properties for Kokoro-app licensed to Mitsubishi-Tanabe. SI is an employee of Life2Bits, Inc. AT received lecture fees from Sumitomo Dainippon Pharma, Eisai, Janssen Pharmaceutical, Meiji-Seika Pharma, Mitsubishi Tanabe Pharma, Otsuka, and Takeda Pharmaceutical. All the other authors have no conflict of interest to declare.
: Informed consent was obtained from all individuals who participated in the two trials and provided their thought records.
: No animal studies were carried out for his study.
